Response Policy Regarding the OGIS-RI Lawsuit
First written in FY2019. 11 of 15 entries say "Restated". Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025AchievedAnnual report
「A settlement was reached on 17 March 2025, resulting in the recognition of the difference between the settlement payment and the relevant amount as extraordinary income, among other matters.」
Regarding the OGIS Research Institute litigation, the matter advanced from the appellate stage following the first-instance judgment to the resolution stage when a settlement was reached on 17 March 2025. - FY2025-H1AdvancedAnnual report
「The company has also filed an appeal, objecting to part of the judgment.」
Regarding the OGIS Research Institute litigation, the company advanced from its previous policy of contesting the case at first instance to filing an appeal itself against parts of the first-instance judgment that it found unacceptable and responding at the appellate level. - FY2024AdvancedAnnual report
「The company has appealed the judgment. In preparation for the possibility that the judgment is ultimately finalized as rendered by the Maebashi District Court, the company recognized ¥566.458 million as an extraordinary loss under provision for litigation loss, representing damages and late-payment damages arising from the matter.」
The company advanced from its previous policy of asserting and contesting its position so that its legitimacy would be fully accepted to specific measures consisting of appealing the first-instance judgment and recognizing a provision in preparation for the judgment becoming final. - FY2024-Q3RestatedAnnual report
「In the future litigation proceedings, the company intends to assert and contest its position so that its legitimacy will be fully accepted.」
Regarding the OGIS Research Institute litigation, the company has reaffirmed its policy of asserting and contesting its position in the litigation proceedings. - FY2024-Q2RestatedAnnual report
「In the future litigation proceedings, the company intends to assert and contest its position so that its legitimacy will be fully accepted.」
Regarding the OGIS Research Institute litigation, the company has reaffirmed its policy of responding by asserting and contesting its legitimacy. - FY2024-Q1RestatedAnnual report
「In the future litigation proceedings, the company intends to assert and contest its position so that its legitimacy will be fully accepted.」
Regarding the OGIS Research Institute litigation, the company has reaffirmed its policy of responding by asserting and contesting its legitimacy. - FY2022RestatedAnnual report
「In the future litigation proceedings, the company intends to assert and contest its position so that its legitimacy will be fully accepted.」
Regarding the OGIS Research Institute litigation, the company has reaffirmed its policy of responding by asserting and contesting its legitimacy. - FY2022-Q3RestatedAnnual report
「In the future litigation proceedings, the company intends to assert and contest its position so that its legitimacy will be fully accepted.」
Regarding the OGIS Research Institute litigation, the company has reaffirmed its policy of asserting and contesting its legitimacy. - FY2021-Q3RestatedAnnual report
「In the future litigation proceedings, the company intends to assert and contest its position so that its legitimacy will be fully accepted.」
Regarding the OGIS Research Institute litigation, the company has reaffirmed its policy of responding by asserting and contesting its legitimacy. - FY2021-Q1RestatedAnnual report
「In the future litigation proceedings, the company intends to assert and contest its position so that its legitimacy will be fully accepted.」
Regarding the OGIS Research Institute litigation, the company has reaffirmed its policy of asserting and contesting its legitimacy. - FY2020RestatedAnnual report
「In the future litigation proceedings, the company intends to assert and contest its position so that its legitimacy will be fully accepted.」
Regarding the OGIS Research Institute litigation, the company has reaffirmed its policy of asserting and contesting its legitimacy. - FY2020-Q3RestatedAnnual report
「In the future litigation proceedings, the company intends to assert and contest its position so that its legitimacy will be fully accepted.」
Regarding the OGIS Research Institute litigation, the company has reaffirmed its policy of responding by asserting and contesting its legitimacy. - FY2020-Q2RestatedAnnual report
「In the future litigation proceedings, the company intends to assert and contest its position so that its legitimacy will be fully accepted.」
Regarding the OGIS Research Institute litigation, the company has reaffirmed its policy of asserting and contesting its position in the litigation proceedings. - FY2020-Q1RestatedAnnual report
「In the future litigation proceedings, the company intends to assert and contest its position so that its legitimacy will be fully accepted.」
Regarding the OGIS Research Institute litigation, the company has reaffirmed its policy of asserting and contesting its position in the litigation proceedings. - FY2019First statedAnnual report
「The company was sued by 株式会社オージス総研 on 26 October 2018 and was served with the complaint on 15 November of the same year. The company intends to assert and contest its position in the litigation proceedings so that its legitimacy will be fully accepted.」
Following the filing of the lawsuit in October 2018 and service of the complaint in November, the company independently disclosed for the first time, as an issue to be addressed, its policy of asserting and contesting its legitimacy in the litigation proceedings.